Author:
Comella Pasquale,Massidda Bruno,Filippelli Gianfranco,Farris Antonio,Natale Donato,Barberis Giuseppe,Maiorino Luigi,Palmeri Sergio,Cannone Michele,Condemi Giovanni,
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference37 articles.
1. Becouarn Y, Ychou M, Ducreux M et al (1998) Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients. J Clin Oncol 16:2739–2744
2. Borner MM, Dietrich D, Stupp R et al (2002) Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancer. J Clin Oncol 20:1759–1766
3. Cassidy J, Tabernero J, Twelves C et al (2004) XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer. J Clin Oncol 22:2084–2091
4. Cassidy J, Douillard J-Y, Twelves C et al (2006) Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes’ C colon cancer: the X-ACT trial. Br J Cancer 94:1122–1129
5. Cassidy J, Clarke S, Diaz-Rubio E et al. (2007) XELOX vs FOLFOX4: efficacy results from XELOX-1/NO16966, a randomised phase III trial in first-line metastatic colorectal cancer (MCRC). Proc Am Soc Clin Oncol Gastrointestinal Cancer Symposium (abstr 270)
Cited by
40 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献